Inhaled corticosteroid use and the incidence of lung cancer in COPD
Conclusions
Inhaled corticosteroid use is not associated with a reduction in lung cancer incidence in patients with COPD. Observational studies reporting such reduction may have been affected by time-related biases and the inclusion of patients with asthma. The proposition of a randomised trial warrants some caution.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Suissa, S., Dell'Aniello, S., Gonzalez, A. V., Ernst, P. Tags: COPD and smoking Original Articles: COPD Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Corticosteroid Therapy | Databases & Libraries | Flonase | Lung Cancer | Respiratory Medicine | Smokers | Study